View More Recent Stories
-
Wells Fargo Downgrades HCA Healthcare Inc (HCA) to Underweight
-
Trump picks RFK Jr for HHS — Here are potential policy implications
-
HCA Holdings (HCA) call put ratio 1 call to 4.4 puts with focus on November 325 puts
-
HCA Healthcare Inc (HCA) PT Raised to $400 at Oppenheimer
-
HCA Healthcare Inc (HCA) PT Lowered to $420 at KeyBanc
-
HCA Healthcare Inc (HCA) PT Lowered to $440 at TD Cowen
-
Mizuho Reiterates Outperform Rating on HCA Healthcare Inc (HCA)
-
HCA Healthcare Inc (HCA) PT Raised to $405 at Cantor Fitzgerald
-
HCA Holdings (HCA) November 405 puts and December 360 puts active as share price down 10.2%
-
HCA Holdings (HCA) Misses Q3 EPS by 8c, Offers Guidance
-
KeyBanc Starts HCA Healthcare Inc (HCA) at Overweight
-
Deutsche Bank Reiterates Buy Rating on HCA Healthcare Inc (HCA)
-
Deutsche Bank Reiterates Buy Rating on HCA Healthcare Inc (HCA)
-
Morgan Stanley Starts HCA Healthcare Inc (HCA) at Equalweight
-
HCA Holdings (HCA) PT Raised to $405 at RBC Capital
-
HCA Holdings (HCA) PT Raised to $430 at Truist Securities
-
HCA Holdings (HCA) Announces Proposed Notes Offering
-
These stocks offer you exposure to rising demand for fertility treatment – Barclays
-
HCA Holdings (HCA) PT Raised to $390 at Oppenheimer
-
HCA Holdings (HCA) PT Raised to $390 at Truist Securities
-
HCA Holdings (HCA) PT Raised to $385 at Mizuho
-
HCA Holdings (HCA) PT Raised to $378 at RBC Capital
-
HCA Holdings (HCA) Tops Q2 EPS by 60c
-
HCA Holdings (HCA) call put ratio 1 call to 2.5 puts into quarter results
-
10 policies if Trump wins and stock implications: Jefferies
-
Midday movers: Nike and Accolade fall; Humana and Infinera rise
